Website & contact details
- Website
Brainomix Limited
- Incorporated
- 2 November 2010 (16 years)
- Industry
- Other information technology service activities (62090)
- Directors
- Khushro Fredoon MehtaOliver Reuss
- Owned by
- Boehringer Ingelheim Venture Fund GMBH
- Accounts type
- Group
- Region
- South East
- Address
- First Floor Seacourt TowerWest WayOxfordOX2 0JJ
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 24 November 2026
- Last conf. stmt
- 10 November 2025
Officers 5 active
Officer details are public data from the Companies House register.
Griffin, Anna Victoria
Secretary · Appointed 1 September 2025
Mehta, Khushro Fredoon
Director · Appointed 1 April 2025
American
Born February 1965 (61)
Reuss, Oliver
Director · Appointed 3 December 2021
German
Born September 1976 (50)
Corporate Director · Appointed 20 August 2019
Papadakis, Michail, Dr.
Director · Appointed 2 November 2010
Greek
Born January 1979 (47)
Officer history (7 former)
1 September 2025
Appointed Griffin, Anna Victoria as Secretary
1 April 2025
Appointed Mehta, Khushro Fredoon as Director
31 March 2025
Resigned Naylor, Ann Jacqueline as Director
17 January 2025
Resigned Strange, Melissa Claire as Secretary
13 December 2024
24 January 2024
Resigned Peitgen, Heinz-Otto, Dr as Director
9 September 2022
Appointed Strange, Melissa Claire as Secretary
3 December 2021
Appointed Reuss, Oliver as Director
3 December 2021
3 December 2021
1 August 2020
Appointed Peitgen, Heinz-Otto, Dr as Director
1 August 2020
Appointed Naylor, Ann Jacqueline as Director
20 August 2019
20 August 2019
19 February 2018
19 February 2018
26 September 2014
1 April 2014
2 November 2010
Appointed Papadakis, Michail, Dr. as Director
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Boehringer Ingelheim Venture Fund GMBH
Corporate entity · Notified 25 June 2021
Owns 25–50% of shares
Holds 25–50% of voting rights
Gmbh
Reg. no. 00000000
Corporate entity · Notified 21 May 2021
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited Company
Reg. no. 13166311
Former controllers (1)
25 June 2021
Ceased Michail Papadakis — Has significant influence or control
Financials
Balance sheet as at 31 December 2025 · group accounts
- Net Assets
- £13,478,116
- Cash
- £11,584,146
- Profit
- (£6,901,423)
- Debt Ratio
- 22%
- Current Ratio
- 5.2x
- Return on Equity
- -51%
Trend
Net Assets
Balance sheet detail
| 2025 | 2020 | 2019 | |
|---|---|---|---|
| Fixed Assets | £398,159 | £113,366 | £91,586 |
| Current Assets | £16,857,428 | £4,993,781 | £2,197,486 |
| Debtors | £3,586,926 | £1,011,155 | |
| Cash | £11,584,146 | £1,388,415 | £1,158,220 |
| Creditors (< 1 year) | £3,217,880 | £466,603 | £1,061,665 |
| Creditors (> 1 year) | £453,676 | ||
| Net Current Assets | £13,639,548 | £4,527,178 | £1,135,821 |
| Net Assets | £13,478,116 | £1,200,638 | |
| Shareholder Funds | £13,478,116 | £1,200,638 | £1,227,407 |
What Brainomix say about themselves
“Brainomix harnesses AI to interpret brain and lung scans in minutes, dramatically improving access to life-saving stroke and lung therapies in 350+ hospitals worldwide.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 November 2026 | Statement of capital following an allotment of shares | |||
| 2 April 2026 | Group of companies' accounts | 31 December 2025 | ||
| 14 November 2025 | Other filing | |||
| 11 November 2025 | Resolutions | |||
| 10 November 2025 | Confirmation statement with updates | 10 November 2025 |
Other companies in this industry
London
Nottingham
Feltham
Hemel Hempstead
Altrincham
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →